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c-Jun, a major transcription factor in the activating protein 1 family of regulatory proteins, is activated by
many physiologic and pathological stimuli. We show here that c-Jun was downregulated in response to osmotic
stress via ubiquitination-dependent degradation by the PHD/RING finger domain of MEKK1, which exhibited
E3 ubiquitin ligase activity toward c-Jun in vitro and in vivo. The reduced c-Jun protein level resulting from
exogenous expression of wild-type MEKK1 and the opposite effect induced by expression of a MEKK1
PHD/RING finger domain mutant were consistent with a higher level of c-Jun protein in MEKK1/ cells than
in corresponding wild-type cells. The deficiency of MEKK1 blocked posttranslational downregulation of c-Jun
in response to osmotic stress. Furthermore, apoptosis induced by osmotic stress was suppressed by overex-
pression of c-Jun, indicating that the downregulation of c-Jun promotes apoptosis.
Activating protein 1 (AP-1) transcription factors are basic
region-leucine zipper proteins and are composed of the Jun
(c-Jun, JunB, and JunD), Fos (c-Fos, FosB, Fra-1, and Fra-2),
Maf (c-Maf, MafB, MafA, MafG/F/K, and Nrl), and ATF
(ATF2, LRF1/ATF3, B-ATF, JDP1, and JDP2) subfamilies (1,
5, 6). AP-1 members form homodimers and/or heterodimers
through their leucine zipper domains and recognize 12-O-tet-
radecanoylphorbol-13-acetate (TPA) response elements [5-T
GA(G/C)TCA-3], cyclic AMP response elements (5-TGAC
GTCA-3), MAF recognition elements [5-TGCTGAC(G)TC
AGCA-3], or antioxidant response elements (5-RTGACnnn
GC-3) (15, 24, 36, 40). Various physiologic and pathological
stimuli, including phorbol ester, growth factors, oncoproteins
(e.g., Src and Ras), proinflammatory cytokines, chemothera-
peutic drugs, osmotic stress, and UV radiation, can activate
c-Jun and other AP-1 transcription factors (2, 27, 31, 39). As a
major component of AP-1, the proto-oncogene c-jun is the
cellular homologue of v-jun, the transforming oncogene in the
genome of avian sarcoma virus 17 (42). c-Jun activation is
instrumental in cell growth and differentiation, apoptosis, cell
transformation, tissue morphogenesis, and inflammatory re-
sponses (19). Mouse embryos lacking c-Jun die at mid- to late
gestation and exhibit impaired hepatogenesis, altered fetal
liver erythropoiesis, and generalized edema (18, 22).
The activity of individual AP-1 components can be con-
trolled by transcriptionally regulated protein expression, inter-
action with other proteins, and posttranslational modifications,
such as phosphorylation, ubiquitination, and sumoylation (32,
33). c-Jun binds to AP-1 binding sites of the c-jun enhancer and
engages in a positive autoregulatory loop (42). c-Jun activity
can be posttranslationally regulated by a mitogen-activated
protein (MAP) kinase signaling pathway. This pathway is a
three-tiered cascade: a MAP kinase is activated by a MAP
kinase/ERK kinase (MEK) or a MAP kinase kinase (MKK),
which is in turn activated by a MEK kinase (MEKK) or MAP
kinase kinase kinase (MKKK) (27). The classic MAP kinase
family consists of three subfamilies: extracellular signal-regu-
lated kinases (ERK; ERK1 and ERK2), c-Jun NH2-terminal
kinases (JNK; JNK1, JNK2, and JNK3), and p38-MAP kinases
(, , , and ) (27). In response to stress stimuli, c-Jun is
activated by JNK phosphorylation at the serine 63 (Ser63) and
Ser73 residues in the transactivation domain near its N termi-
nus (42). Acting as a MAP kinase kinase kinase, MEKK1
phosphorylates several different MKKs; its strongest activity is
directed toward MKK4, an upstream kinase for JNKs (47).
In addition to functioning as a Ser/threonine protein kinase,
MEKK1 acts as a ubiquitin (Ub) E3 ligase via its N-terminal
plant homeodomain (PHD) (29, 46), the structure of which is
closely related to the RING finger domain, with seven cys-
teines (Cys) and a histidine (His) spatially arranged in a C4HC3
consensus sequence (8). Because of this striking similarity, the
MEKK1 PHD domain is regarded as an atypical RING finger
domain (3) and is currently designated a PHD/RING finger
domain. Unlike the enzymatic HECT (homologous to the
E6-AP C terminus) domain E3s, the PHD/RING finger do-
main, the RING finger domain, and the U box E3 ligases do
not form a thioester with Ub or transfer Ub directly to sub-
strates but rather function as adaptors, facilitating the interac-
tion between various distinct substrates and a Ub-conjugating
enzyme (E2) (4, 8). Polyubiquitination mediated by a Ub-
activating enzyme (E1), an E2, and an E3 targets substrate
proteins for proteasome-mediated degradation.
In this report, we demonstrate that c-Jun is downregulated
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in response to osmotic stress and that MEKK1, which exhibits
E3 Ub ligase activity toward c-Jun, plays an important role in
osmotic stress-induced and Ub/proteasome-dependent c-Jun
degradation.
MATERIALS AND METHODS
Cells and cell culture conditions. NIH 3T3 mouse fibroblasts, 3Y1 rat fibro-
blasts, MEKK1/ and MEKK1/ mouse 3T3 fibroblasts, and 293T human
embryonic kidney cells were maintained in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum (HyClone, Logan, UT).
Cell stimulation with osmotic stress. Cells were grown in medium containing
0.5% serum for 16 h and then treated with sorbitol (500 mM).
Materials. MG132 was from Calbiochem (San Diego, CA). Polyclonal anti-
body against JNK1 (C-17) and hemagglutinin (HA) and monoclonal antibodies
against phospho-JNK (G-7) and phospho-c-Jun (KM-1) were from Santa Cruz
Biotechnology (Santa Cruz, CA). Cycloheximide, TPA, sorbitol, and monoclonal
antibodies against actin, poly-His, and tubulin were from Sigma (St. Louis, MO).
Monoclonal anti-Ub antibody was from Zymed Laboratories (South San Fran-
cisco, CA). Hoechst 33342, Alexa Fluor 488 goat anti-mouse antibody, and Alexa
Fluor 594 goat anti-rabbit antibody were from Molecular Probes (Eugene, OR).
Epidermal growth factor (EGF) was from Upstate Biotechnology (Lake Placid,
NY). Anti-c-Jun monoclonal antibody was from BD Biosciences (San Jose, CA).
DNA constructs and mutagenesis. A PCR-amplified human c-jun cDNA was
cloned into pHis8 vector between BamHI and HindIII. Plasmids for the gluta-
thione S-transferase (GST)-MEKK1 PHD/RING finger, GST-MEKK1 PHD/
RING finger C433A, HA-MEKK1, HA-MEKK1 C433/478A, HA-MEKK1
D1369A, and pCep4 were described previously (29).
Immunoprecipitation and immunoblotting analysis. Extraction of proteins
with a modified buffer from cultured cells was followed by immunoprecipitation
and immunoblotting with corresponding antibodies as described previously (28).
The immunoblotting analysis with the anti-Ub antibody was carried out after the
membranes had been preincubated with denaturing buffer (6 M guanidine-HCl,
20 mM Tris-HCl [pH 7.5], 5 mM -mercaptoethanol, and 1 mM phenylmethyl-
sulfonyl fluoride) for 30 to 60 min at 4°C followed by extensive washing in
phosphate-buffered saline.
Purification of recombinant proteins. The wild-type (WT) or mutant GST-
MEKK1 PHD/RING finger protein, His-E1, His-E2 (UbcH5B), GST-Ub, and
His-c-Jun were expressed in bacteria and purified as described previously (29).
In vitro ubiquitination assays. In vitro ubiquitination reactions were carried
out as described previously (21). Approximately 3 g of WT or mutant GST-
MEKK1 PHD/RING finger and His-c-Jun was incubated with 50 to 500 nM
His-E1, 0.5 to 5 M His-UbcH5B, 10 M GST-Ub, and 2 mM ATP in reaction
buffer (50 mM Tris-HCl [pH 7.5], 2.5 mM MgCl2, and 0.5 mM dithiothreitol).
Immunofluorescence analysis. Cells were fixed and incubated with primary
antibodies, Alexa Fluor dye-conjugated secondary antibodies, and Hoechst
33342 according to standard protocols. Cells were examined using a fluorescent
deconvolutional microscope (Zeiss, Thornwood, NY) with a 60-Å oil immersion
objective. Axio Vision software from Zeiss was used to deconvolve Z-series
images.
Cell apoptosis analysis. Apoptosis was measured using the annexin V-fluo-
rescein isothiocyanate (FITC) apoptosis detection kit from BD Biosciences ac-
cording to the manufacturer’s instructions. Cells were treated with or without
sorbitol for 12 h. Both adherent and floating cells were collected and resus-
pended in 1	 cold binding buffer (10 mmol/liter HEPES [pH 7.4], 150 mmol/liter
NaCl, 2.5 mmol/liter CaCl2, 1 mmol/liter MgCl2, and 4% bovine serum albumin)
for analysis. Cells were also stained with propidium iodide to detect dead cells.
Analysis was done on a FACSCalibur flow cytometer (BD Biosciences) using
CellQuest Pro software (BD Biosciences). Unstained cells were classified as “live
or survival” cells and those stained with annexin V only as “early apoptotic,”
while cells stained with both annexin V and propidium iodide were classified as
“late apoptotic” and those stained with propidium iodide only as “dead.”
RESULTS
Osmotic stress-induced Ub/proteasome-mediated c-Jun degra-
dation. Extracellular stimuli such as tumor necrosis factor al-
pha, UV B irradiation, EGF, nerve growth factor, and basic
fibroblast growth factor increase c-jun mRNA and protein
levels (7, 11, 20, 41). To examine the effect of osmotic stress on
c-Jun expression, we stimulated 3Y1 rat fibroblasts with sorbi-
tol for up to 6 h. Immunoblotting with an anti-c-Jun antibody
revealed that c-Jun protein was downregulated at 6 h of sor-
bitol osmotic stimulation, whereas tubulin levels remained
constant (Fig. 1A, left panel). Similar results were obtained
with NIH 3T3 mouse fibroblasts (data not shown). c-Jun was
phosphorylated at Ser63 within 1 h of sorbitol treatment, and
prolonged sorbitol treatment reduced the amount of phosphory-
lated c-Jun to an extent corresponding to the decrease in c-Jun
protein (Fig. 1A, left panel). In contrast, stimulation of NIH
3T3 cells with serum, EGF, or TPA for 1 or 6 h resulted in
phosphorylation of c-Jun and sustained upregulation of c-Jun
expression. These data indicate that that the level of c-Jun
protein is regulated differentially depending on the extracellu-
lar stimuli and cellular milieu involved (Fig. 1A, right panel).
Pretreatment with the proteasome inhibitor MG132 in the
presence of the de novo protein synthesis inhibitor cyclohexi-
mide (CHX) reduced the sorbitol-induced c-Jun downregula-
tion (Fig. 1B), suggesting that proteasome activity is involved
in c-Jun downregulation. To examine the role of phosphoryla-
tion in sorbitol-induced posttranslational c-Jun downregula-
tion, 293T cells were transiently transfected with WT His-c-Jun
or a His-c-Jun S63/73A mutant, in which JNK phosphorylation
sites Ser63 and Ser73 are mutated to alanine (Ala). Pretreat-
ment with CHX before sorbitol revealed that the mutant, act-
ing similarly to its WT counterpart, was downregulated (Fig.
1C). CHX treatment alone resulted in strong phosphorylation
of WT c-Jun but not of the mutant. Immunoblotting of immu-
noprecipitated WT His-c-Jun or the S63/73A mutant from
293T cells with an anti-Ub antibody demonstrated sorbitol-
induced polyubiquitination of both the WT and mutant pro-
teins, as shown by the enhanced smear of the more slowly
migrating bands (Fig. 1D). These data indicate that the process
of Ub/proteasome-mediated protein degradation is involved in
the sorbitol-induced downregulation of c-Jun, which is inde-
pendent of its phosphorylation at S63/73 by JNK.
MEKK1 PHD/RING finger domain-dependent c-Jun ubiq-
uitination. Sorbitol treatment activates MEKK1 (29) and in
turn the MAP kinase cascade, leading to c-Jun phosphoryla-
tion by JNK1/2 (47). The MEKK1 PHD/RING finger domain
possesses E3 ligase activity (29, 46). To determine whether
MEKK1 has E3 ligase activity toward c-Jun, we performed an
in vitro ubiquitination assay. Purified bacterially expressed His-
c-Jun was incubated with purified E1, E2 (UbcH5B), Ub, and
GST-MEKK1 PHD/RING finger domain WT protein or the
C433A mutant protein, in which the first Cys in the PHD/
RING finger domain is mutated to Ala, thereby abolishing its
E3 ligase activity (29). Immunoblotting with an anti-c-Jun an-
tibody revealed that WT protein but not the C433A mutant
stimulated oligoubiquitination of c-Jun (Fig. 2A). Thus, the
MEKK1 PHD/RING finger domain has E3 ligase activity to-
ward nonphosphorylated c-Jun in vitro.
To test whether MEKK1 is an E3 ligase for c-Jun ubiqui-
tination in vivo, 293T cells were transfected with HA-tagged
WT MEKK1 or the C433/478A MEKK1 E3 ligase mutant, in
which both the first and penultimate Cys in the PHD/RING
finger domain are mutated to Ala. Immunoprecipitation of
c-Jun followed by immunoblotting with an anti-Ub antibody
showed that the overexpression of WT MEKK1 but not the
C433/478A mutant resulted in polyubiquitination and reduced
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protein levels of c-Jun (Fig. 2B). Relatively similar amounts of
c-Jun protein in the cells transfected with the vector and the
C433/478A mutant were detected in the immunoprecipitates
(Fig. 2B), in contrast to the enhanced level of total c-Jun
observed by immunoblotting whole-cell protein from the cells
expressing the C433/478A mutant (Fig. 3). This disparity oc-
curred because the amount of anti-c-Jun antibody used for the
immunoprecipitation was limiting and the antibodies were sat-
urated with c-Jun.
Immunoblotting of immunoprecipitated MEKK1 with an
anti-c-Jun antibody revealed a weak association between en-
dogenous c-Jun and WT HA-MEKK1 or the D1369A kinase-
dead mutant and an enhanced interaction between endoge-
nous c-Jun and the C433/478A mutant (Fig. 2C). Thus, the
regulation of c-Jun ubiquitination in vivo depends on the in-
tegrity of the MEKK1 PHD/RING finger domain, mutation of
which enhances the association between MEKK1 and c-Jun.
This enhanced association could be due to an increased
amount of c-Jun protein or to an increased stability of the
complex caused by the PHD/RING finger domain mutation.
Immunofluorescence studies demonstrated that although
MEKK1 was localized primarily in the cytosol, colocalization
of MEKK1 with c-Jun in the nucleus could be observed (Fig.
2D). This finding is consistent with the detection of nuclearly
localized MEKK1 by nucleus fractionation analyses (data not
shown). These results imply that c-Jun ubiquitination by
MEKK1 occurs in the nucleus.
MEKK1 PHD/RING finger domain-dependent c-Jun degra-
dation. To test whether MEKK1 regulates c-Jun expression in
vivo, 293T cells were transfected with HA-tagged WT MEKK1,
the C433/478A MEKK1 E3 ligase mutant, or the D1369A
kinase-dead mutant. As detected by immunoblotting analysis,
expression of WT MEKK1 or the D1369A mutant moderately
downregulated c-Jun, whereas the PHD/RING finger domain
mutant significantly upregulated c-Jun (Fig. 3). In contrast, the
level of JNK1 protein was unaffected. Expression of both WT
MEKK1 and the C433/478A mutant activated JNK, as shown
by immunoblotting with an anti-phospho-JNK antibody,
whereas only the C433/478A mutant hampered c-Jun degra-
dation. Furthermore, the kinase-dead mutant, which did not
activate JNK, was still able to reduce c-Jun expression. These
results indicate that expression of the MEKK1 E3 ligase mu-
tant affects normal c-Jun turnover and strongly suggest that
c-Jun downregulation is independent of JNK activation.
MEKK1 deficiency blocked posttranslational downregula-
tion of c-Jun in response to osmotic stress. To examine the
FIG. 1. Osmotic stress-induced Ub/proteasome-mediated c-Jun degradation. Immunoblotting (Western blotting [WB]) analyses were carried
out with the indicated antibodies. Tubulin was used as an input control. (A) Serum-starved 3Y1 cells (left panel) or NIH 3T3 cells (right panel)
were treated with sorbitol (500 mM), 20% fetal bovine serum, EGF (100 ng/ml), or TPA (400 nM) for the indicated times. (B) 3Y1 cells were
treated with CHX (200 g/ml) for 30 min, then MG132 (50 M) for 30 min, and finally sorbitol with CHX and MG132 for 6 h. (C) 293T cells
transiently transfected with WT pMT35-His-c-Jun or pMT35-His-c-Jun S63/73A were treated with CHX (200 g/ml) for 30 min and then with or
without sorbitol for 6 h. (D) Immunoprecipitation (IP) of WT His-c-Jun or His-c-Jun S63/73A from 293T cells with or without sorbitol treatment
for 1 h.
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effect of MEKK1 deficiency on c-Jun expression, MEKK1/
and MEKK1/ fibroblasts were treated with sorbitol for 6 h
or left untreated. Consistent with the posttranslational regula-
tion of c-Jun by MEKK1, the level of c-Jun protein (Fig. 4A),
but not the level of c-jun mRNA measured by real-time quan-
titative reverse transcription-PCR analysis (data not shown), was
higher in untreated MEKK1/ fibroblasts than in MEKK1/
cells. Sorbitol stimulation reduced c-Jun levels in both
MEKK1/ and MEKK1/ cells.
Because c-Jun could in principle be regulated at both the
posttranslational and protein synthesis levels, sorbitol-induced
c-Jun downregulation in MEKK1/ cells might be due to
reduced protein synthesis. Treatment with CHX, which blocks
protein synthesis and eliminates the effects of transcriptional
regulation, abrogated sorbitol-induced c-Jun downregulation
in MEKK1/ cells but not in MEKK1/ cells, although it
should be noted that the overall level of c-Jun was lower in the
CHX-treated cells as expected (Fig. 4A). These data demon-
strate that MEKK1 is necessary for sorbitol-induced posttrans-
lational degradation of c-Jun. The fact that sorbitol still in-
duced a decrease in c-Jun expression in MEKK1/ cells
suggests that nonposttranslational regulation is another impor-
tant mechanism for regulating c-Jun levels. Reconstituting the
expression of WT MEKK1 or the C433/478A mutant in
MEKK1/ cells by stable transfection showed that the expres-
sion of WT MEKK1, but not its mutant lacking E3 ligase
functionality, reduced c-Jun protein expression in the absence
of sorbitol (Fig. 4B). These results further corroborate the
function of MEKK1 as an E3 ligase regulating c-Jun protein
levels.
Antiapoptotic function of c-Jun in sorbitol-induced apopto-
sis. Prolonged stress stimuli, such as sorbitol treatment, can
FIG. 2. MEKK1 PHD/RING finger domain-dependent c-Jun ubiquitination. Immunoblotting and immunofluorescence analyses were carried
out with the indicated antibodies. (A) In vitro ubiquitination reactions with purified His-c-Jun with or without the WT GST-MEKK1 PHD/RING
finger or the GST-MEKK1 PHD/RING finger C433A mutant protein. (B) 293T cells transiently transfected with pCep4 (vector), WT HA-MEKK1,
or HA-MEKK1 C433/478A for 48 h were used for immunoprecipitation with an anti-c-Jun antibody. (C) 293T cells transiently expressing WT
HA-MEKK1, HA-MEKK1 C433/478A, or HA-MEKK1 D1369A for 48 h were used for immunoprecipitation with an anti-HA antibody. (D) NIH
3T3 cells expressing HA-MEKK1 were stained with an anti-c-Jun antibody (red), an anti-HA antibody (green), or Hoechst 33342 (blue). Yellow
indicates overlap of red and green.
VOL. 27, 2007 c-Jun UBIQUITINATION AND DEGRADATION BY MEKK1 513
cause apoptosis (12, 30). MEKK1/ cells reconstituted for
expression of the C433/478A MEKK1 mutant showed in-
creased resistance to sorbitol-induced apoptosis, in contrast to
MEKK1/ cells reconstituted for expression of WT MEKK1,
implying that c-Jun promotes cell survival against osmotic
stress (Fig. 5A). To further clarify the role of c-Jun in sorbitol-
induced apoptosis, NIH 3T3 cells transiently expressing His-c-
Jun were treated with or without sorbitol for 12 h. NIH 3T3
cells overexpressing c-Jun showed an increased resistance to
sorbitol-induced apoptosis, in contrast to untransfected cells,
which displayed condensed and fragmented nuclei (Fig. 5B and
C). These results indicate that c-Jun has antiapoptotic effects
and that downregulation of c-Jun by MEKK1 promotes sorbi-
tol-induced apoptosis.
DISCUSSION
In its role as a major AP-1 transcription factor, c-Jun, phos-
phorylated and activated in response to diverse extracellular
stimuli, regulates gene expression. Stimulation with serum,
EGF, or TPA induced c-Jun phosphorylation and increased its
expression. In contrast, sorbitol-induced c-Jun phosphoryla-
tion diminished after prolonged treatment and was accompa-
nied by reduced c-Jun expression. These results indicate that
c-Jun activity is dynamically regulated via the dual mechanisms
of phosphorylation and protein expression and that the acti-
vation of c-Jun is transient or sustained depending on the
nature of the extracellular stimuli to which the cells are ex-
posed.
The mutation of JNK phosphorylation sites in c-Jun did not
hamper sorbitol-induced c-Jun ubiquitination and downregula-
tion. Furthermore, MEKK1 ubiquitinated nonphosphorylated c-
Jun in vitro. These findings emphasize that JNK-dependent c-Jun
phosphorylation is not required for sorbitol-induced ubiqui-
tination and downregulation of c-Jun. It was previously shown
that the FBW7-containing Skp1/cullin/F-box protein complex,
an E3 ligase, recognizes and degrades S63/73-phosphorylated
c-Jun but not nonphosphorylated c-Jun in a neuronal system
(34). However, this observation was not supported by a more
recent report that showed that in the absence of extracellular
stimulation, phosphorylation of Thr239 and Ser243 by GSK3,
but not of Ser63/73, of c-Jun is required for FBW7-mediated
c-Jun degradation. v-Jun containing a Ser243-to-phenylalanine
FIG. 3. MEKK1 PHD/RING finger domain-dependent c-Jun deg-
radation. 293T cells transiently expressing WT HA-MEKK1, HA-
MEKK1 C433/478A, or HA-MEKK1 D1369A for 48 h were used for
immunoblotting analysis with the indicated antibodies. Actin was used
as an input control.
FIG. 4. MEKK1 deficiency blocked posttranslational downregulation of c-Jun in response to osmotic stress. Immunoblotting analyses were
carried out with the indicated antibodies. Actin was used as an input control. (A) MEKK1/ and MEKK1/ cells were treated with or without
sorbitol in the presence or absence of CHX (200 g/ml) for 6 h. (B) Cell lysates of MEKK1/ cells, MEKK1/ cells, and MEKK1/ cells with
reconstituted expression of WT MEKK1 or MEKK1 C433/478A.
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mutation escapes recognition by FBW7 (43). Enhanced c-Jun
degradation in response to osmotic stress is different from
human De-etiolated 1 (hDET1)-promoted ubiquitination and
degradation of c-Jun, which occurs in nonstimulated cells by
assembling a multisubunit Ub ligase containing DNA damage
binding protein 1 (DDB1), cullin 4A (CUL4A), regulator of
cullins 1 (ROC1), and constitutively photomorphogenic 1
(COP1) (44). Our results are also distinct from the finding that
Itch, a HECT domain-containing E3, promotes c-Jun and
JunB ubiquitination in a T-cell system (17). In this system,
c-Jun ubiquitination is independent of c-Jun S63/73 phosphor-
ylation but depends on the activation of JNK. Activated JNK1
phosphorylates Itch at S199, S232, and T222, which disrupts an
inhibitory interaction between the WW domain of Itch and its
catalytic HECT domain and induces a conformational change
that greatly enhances Itch E3 ligase activity (16).
JNK1 and JNK2 differentially regulate c-Jun phosphoryla-
tion and stability, which are enhanced in JNK2/ fibroblasts,
whereas the absence of JNK1 has the opposite effect (37). In
our experiments with fibroblasts, both WT MEKK1 and the E3
ligase-defective MEKK1 C433/478A mutant were able to acti-
vate JNK1/2; however, ectopic expression of the MEKK1
C433/478A mutant, but not WT MEKK1, significantly in-
creased the level of c-Jun protein. Furthermore, the D1369A
kinase-dead MEKK1 mutant, which did not activate JNK, was
still able to downregulate c-Jun expression. These results sug-
gest that neither JNK1 activation nor JNK2 activation is required
for sorbitol-induced c-Jun degradation. Therefore, c-Jun ubiqui-
tination is likely mediated by multiple E3 ligases depending on
the cell and tissue type involved and the cellular regulatory influ-
ences that the cells are receiving. In addition to c-Jun, which is a
substrate of MEKK1 E3 ligase, MEKK1 also regulates the sta-
bility of another AP-1 family member, Fra-2, by inducing Fra-2
ubiquitination and degradation (10).
c-Jun was downregulated in MEKK1/ cells in response to
osmotic stress. Nevertheless, MEKK1 deficiency blocked sor-
bitol-induced c-Jun downregulation in the presence of a de
novo protein synthesis inhibitor. These results indicate that
MEKK1 plays an important role in the posttranslational regula-
tion of c-Jun and that osmotic stress-induced c-Jun downregula-
tion results from the combined effects of MEKK1-mediated ubiq-
uitination and a potential transcriptional repression. Indeed,
osmotic stimulation results in transcriptional repression of c-jun
by regulating histone deacetylase 3 (our unpublished data).
Both JNK and c-Jun may have pro- and antiapoptotic func-
tions that depend on the cell or tissue type and the specific
apoptotic stimuli involved (21, 25, 35). Tumor necrosis factor
alpha (TNF-) induces sustained JNK activation by inhibition
of JNK-inactivating phosphatases (23). Activated JNK en-
hances Itch E3 ligase activity, which ubiquitinates and de-
grades antiapoptotic protein c-FLIP, an inhibitor of caspase 8,
and promotes TNF--induced apoptosis (9). JNK phosphoryl-
ates the proapoptotic BH3-only subgroup of Bcl2-related pro-
teins, Bim and Bmf, and induces Bax/Bak-dependent apoptosis
(26). However, the JNK antiapoptotic function was also exem-
plified by a report showing that interleukin 3 withdrawal-in-
duced apoptosis is suppressed by expression of a constitutively
active JNK, which phosphorylates BAD at threonine 201,
thereby inhibiting BAD association with the antiapoptotic mol-
ecule BCL-XL (48). Both WT MEKK1 and the C433/478A
MEKK1 mutant can activate JNK. Nevertheless, MEKK1/
cells reconstituted for expression of the C433/478A MEKK1
mutant, which have a higher level of c-Jun expression than
MEKK1/ cells reconstituted for expression of WT MEKK1,
showed increased resistance to sorbitol-induced apoptosis.
These data imply that c-Jun, whose stability is regulated by
MEKK1 but not JNK, plays a role in cells against apoptosis
induced by osmotic stress. The fact that overexpression of
c-Jun significantly blocked sorbitol-induced apoptosis provides
additional evidence of the antiapoptotic functions of c-Jun.
These results are consonant with the fact that c-Jun/ fibro-
blasts are much less capable than c-Jun/ cells of escaping
UV-induced apoptosis (45). These results are also consistent
with the massive level of apoptosis of hepatoblasts and eryth-
roblasts that results from c-Jun deficiency in the developing
mouse liver in vivo (14). Although more studies are needed
to characterize the antiapoptotic functions of c-Jun, it has
been shown that c-Jun suppresses p53 transcription by di-
rectly binding to a variant AP-1 site in the p53 promoter
(38). Additionally, c-Jun protects hepatocytes from apopto-
FIG. 5. Antiapoptotic function of c-Jun in sorbitol-induced apoptosis. (A) MEKK1/ cells with reconstituted expression of WT MEKK1 or
MEKK1 C433/478A were treated with or without sorbitol (500 mM) for 12 h, followed by staining with annexin V-FITC and propidium iodide,
before being analyzed by flow cytometry. The relative levels of surviving cells were normalized to the levels of untreated cells. Data are means plus
standard deviations for three independent experiments. (B) Representative photomicrographs of immunofluorescence analyses. Two days after
transfection of NIH 3T3 cells with pMT35-His-c-Jun, the cells were treated with sorbitol for 12 h. Cells expressing His-c-Jun (red) were detected
with an anti-His antibody. Nuclei were stained with Hoechst 33342 (blue). The arrows point to cells expressing His-c-Jun. (C) Surviving cells
transfected with or without pMT35-His-c-Jun and treated with sorbitol were counted under a fluorescent deconvolutional microscope. The relative
levels of cell survival were normalized to the levels of untreated cells. Data are means plus standard deviations for three independent experiments.
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sis by antagonizing p53 activity in liver-specific c-Jun condi-
tional mutant mice (13).
In summary, our results reveal a novel mechanism for the
regulation of signal transduction in response to extracellular
stimuli and provide a model for the dynamic regulation of
c-Jun expression during stress responses in living cells (Fig. 6).
c-Jun is phosphorylated and activated by the MEKK1-MKK4/
7-JNK1/2 kinase cascade in response to brief treatment with
sorbitol. Activated c-Jun counteracts extracellular stress by
transcriptionally suppressing the expression of proapoptotic
proteins or by activating the expression of antiapoptotic pro-
teins, which allows cells to recover from transient stress stimuli.
When exposure to the stress is prolonged, c-Jun expression
is downregulated, which involves MEKK1-mediated ubiqui-
tination and degradation of c-Jun. The depletion of c-Jun,
which downregulates the activation of c-Jun during an early
stage of exposure to stress, promotes osmotic stimulation-in-
duced apoptosis. Our proposed model for the dynamic regu-
lation of cell survival molecules, which are activated at an early
stage of stress for counteracting apoptosis and downregulated
at a late stage for promoting apoptosis, may represent an
important general cellular mechanism.
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